Published in Cancer Weekly, October 19th, 2004
The patents, granted in the European Union, Japan, and Russia, offer additional validation to the innovative technology Gene Express is using to assist academic institutions with genomic research; pharmaceutical and biotechnology companies to develop new drugs; and clinical diagnostic companies in development of innovative and patentable molecular diagnostic tests for cancers, infectious diseases, and other therapeutic...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.